Sep 1, 2019

CRISPR Screening in T Cells Identifies Potential Immunotherapy Targets

Cancer Discovery

Abstract

A CRISPR screen in CD8+ T cells revealed genes that modulate T-cell effector functions, including Dhx37.

  • References
  • Citations

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

T-Lymphocyte
Genes
CD8-Positive T-Lymphocytes
Screening Generic
Clustered Regularly Interspaced Short Palindromic Repeats
Immunotherapy

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.